Search results for "MCI"

showing 10 items of 228 documents

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie e…

2011

Resume Objectif de l’etude Etudier l’apport de la chimioradiotherapie concomitante suivie de chimiotherapie dans le cancer pancreatique localement evolue, par rapport a la chimiotherapie seule. Patients et methodes Cent dix-neuf patients atteints d’un cancer pancreatique localement evolue, avec indice de performance de 0 a 2 selon l’Organisation mondiale de la sante, ont ete randomises entre une chimioradiotherapie concomitante d’induction (60 Gy, 2 Gy/fraction ; perfusion concomitante de 5-fluoro-uracile de 300 mg/m2 par jour, de j1 a j5 pendant six semaines ; cisplatine, 20 mg/m2 par jour, de j1 a j5 pendant la premiere et la cinquieme semaines) et une chimiotherapie d’induction par gemci…

Gynecology0303 health sciencesmedicine.medical_specialtybusiness.industryGemcitabine3. Good health03 medical and health sciences0302 clinical medicineCombined treatmentOncology030220 oncology & carcinogenesisOverall survivalmedicineRadiology Nuclear Medicine and imagingbusinessINDUCTION TREATMENT030304 developmental biologymedicine.drugCancer/Radiothérapie
researchProduct

Classification of the lesions observed in female genital schistosomiasis

2014

Author's version of an article in the journal: International Journal of Gynecology and Obstetrics. Also available from the publisher at: http://dx.doi.org/10.1016/j.ijgo.2014.07.014

GynecologyFemale circumcisionmedicine.medical_specialtybusiness.industryConsensus Development Conferences as TopicGeneral surgeryObstetrics and GynecologySchistosomiasisVDP::Medical disciplines: 700::Health sciences: 800General Medicinemedicine.diseasesandy patcheslesionsSchistosomiasis haematobiaclassificationfemale genital schistosomiasismedicineHumansFemalebusinessrubbery papules
researchProduct

Knowledge, attitudes and practices of primary healthcare professionals to female genital mutilation in Valencia, Spain: are we ready for this challen…

2017

Background The practice of Female Genital Mutilation (FGM) is a deeply-rooted tradition in 30 Sub-Saharan and Middle-East countries which affects approximately 200 million women and girls worldwide. The practice leads to devastating consequences on the health and quality of life of women and girls in both the short and long term. Globalizing processes and migration flows have recorded cases of this practice worldwide representing for healthcare professionals an emerging challenge on how to approach their healthcare in a transcultural, ethical and respectful way. No survey to assess knowledge, attitudes and practices on FGM among primary healthcare professionals has been conducted in the Val…

Health Knowledge Attitudes PracticeWomen’s healthHealth administration0302 clinical medicinePregnancySurveys and QuestionnairesHealth carePrevalence030212 general & internal medicinePrimary health careeducation.field_of_study030219 obstetrics & reproductive medicineSocial worklcsh:Public aspects of medicineHealth PolicyNursing researchGenitalia FemaleMiddle AgedProfessional practiceAtenció primàriaCircumcision FemaleFemaleClinical CompetenceResearch ArticleKAP studyAdultTypologymedicine.medical_specialtyHealth PersonneleducationPopulationMidwiferyMiddle EastYoung Adult03 medical and health sciencesQuality of life (healthcare)medicineHumanseducationFemale genital mutilationAgedbusiness.industryPublic healthlcsh:RA1-1270Cross-Sectional StudiesGynecologySpainFamily medicineQuality of LifebusinessDelivery of Health CareBMC Health Services Research
researchProduct

La perversión de los ideales / 1

2008

IdealesSocial-liberalismoDerechoVidal-Beneyto JoséPOLÍTICATransforamcionesPerversiónMundo occidentalPublicaciones: Obra periodística: Columnas y artículos de opiniónPerversión democráticaEuropa occidentalLiberalismoFormaciones políticasCríticaRupturistaMovimientos políticosSocialdemocraciaReligiónIdeal liberalIDEOLOGÍAValores
researchProduct

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells

2020

A new series of eighteen imidazo [2,1-b] [1,3,4]thiadiazole derivatives was efficiently synthesized and screened for antiproliferative activity against the National Cancer Institute (NCI-60) cell lines panel. Two out of eighteen derivatives, compounds 12a and 12h, showed remarkably cytotoxic activity with the half maximal inhibitory concentration values (IC50) ranging from 0.23 to 11.4 μM, and 0.29–12.2 μM, respectively. However, two additional compounds, 12b and 13g, displayed remarkable in vitro antiproliferative activity against pancreatic ductal adenocarcinoma (PDAC) cell lines, including immortalized (SUIT-2, Capan-1, Panc-1), primary (PDAC-3) and gemcitabine-resistant (Panc-1R), elici…

Inhibition of migrationAntimetabolites AntineoplasticEpithelial-Mesenchymal Transition3Modulation of EMTPTK2VimentinAntineoplastic AgentsApoptosisThiophenesAntiproliferative activity1-b][1DeoxycytidinePancreatic ductal adenocarcinomaThiadiazolesSDG 3 - Good Health and Well-beingCell MovementPancreatic cancerDrug DiscoveryThiadiazolesmedicineTumor Cells CulturedImidazo[21-b][134]thiadiazole derivativesHumansPTK2/FAKIC50Cell ProliferationImidazo[2Pharmacologybiology4]thiadiazole derivativesChemistryOrganic ChemistryDrug SynergismGeneral Medicinemedicine.diseaseGemcitabinePancreatic NeoplasmsCell cultureDrug Resistance NeoplasmImidazo[21-b][134]thiadiazole derivatives Pancreatic ductal adenocarcinoma Antiproliferative activity Inhibition of migration Spheroids shrinkage Modulation of EMT PTK2/FAKbiology.proteinCancer research/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPhosphorylationSpheroids shrinkageTyrosine kinaseCarcinoma Pancreatic DuctalEuropean Journal of Medicinal Chemistry
researchProduct

Ryt obrzezania w Gilgal (Joz 5,2-9) momentem odnowienia relacji narodu wybranego z JHWH

2020

Przymierzom biblijnym często towarzyszyły znaki, np. tęcza (Rdz 9,12–17), krew cielców (Wj 24,3–8) czy też chleb i wino (Łk 22,19–20). Zewnętrznym znakiem przymierza, jakie Bóg zawarł z Abrahamem, było obrzezanie (Rdz 17,9–14). Obrzęd ten został zaniedbany podczas czterdziestoletniej wędrówki przez pustynię. Jednak po przejściu Jordanu JHWH upomniał się o ten znak. Tak jak obrzezanie fizyczne było warunkiem wzięcia w posiadanie Ziemi Obiecanej, tak obrzezanie serca było warunkiem utrzymania tej ziemi w rękach Izraelitów oraz gwarantowało bezpieczeństwo i pomyślność. Niniejszy artykuł prezentuje szczegółową analizę perykopy Joz 5,2–9, w której jest mowa o obrzezaniu w Gilgal i o odnowieniu r…

JoshuaHańba Egiptunowy i wierny ludobrzezanie sercaGilgalJozuedojrzałośćcovenantReproach of Egyptnew and faithful peopleobrzezanie fizyczneprzymierzecircumcision of the heartflint knivesmaturitykrzemienne nożephysical circumcisionStudia Koszalińsko-Kołobrzeskie
researchProduct

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement

2022

Background: Classic Kaposi’s sarcoma (CKS) is a rare, multifocal, endothelial cell neoplasm that typically occurs in elderly people with previous infection by human herpes virus-8. Prospective trials are rare, and the choice of drugs relies on prospective trials performed on HIV-associated Kaposi’s sarcoma (KS). Pegylated liposomal anthracyclines and taxanes are considered the standard first- and second-line chemotherapy, respectively. Despite the indolent biologic behavior, the natural history is characterized by recurrent disease. This condition of chronic administration of cytotoxic drugs is often associated with immediate/long-term adverse events. Methods: This was an observational, ret…

Kaposi’s sarcomaOncologygemcitabine
researchProduct

Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma.

2016

11062Background: Human equilibrative nucleoside transporter 1 (hENT1) is the major gemcitabine transporter into cells. Gemcitabine is an active drug in different sarcoma subtypes including leiomyos...

LeiomyosarcomaDrugCancer Researchbiologybusiness.industrymedia_common.quotation_subjectTransporterEquilibrative nucleoside transporter 1medicine.diseaseGemcitabineOncologybiology.proteinCancer researchMedicineAngiosarcomaSarcomabusinessmedicine.drugmedia_commonJournal of Clinical Oncology
researchProduct

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

2014

Lung cancer is the most common cause of cancer-related mortality worldwide, urging the discovery of novel molecular targets and therapeutic strategies. Stem cells have been recently isolated from non-small cell lung cancer (NSCLC), thus allowing the investigation of molecular pathways specifically active in the tumorigenic population. We have found that Bcl-XL is constantly expressed by lung cancer stem cells (LCSCs) and has a prominent role in regulating LCSC survival. Whereas chemotherapeutic agents were scarcely effective against LCSC, the small molecule Bcl-2/Bcl-XL inhibitor ABT-737, but not the selective Bcl-2 inhibitor ABT-199, induced LCSC death at nanomolar concentrations. Differen…

Lung NeoplasmsMice SCIDPharmacologyPiperazinesAntineoplastic AgentNitrophenolsMiceMice Inbred NODCarcinoma Non-Small-Cell LungCytotoxic T cellNon-Small-Cell Lungeducation.field_of_studySulfonamidesTumorAnimals; Antineoplastic Agents; Biphenyl Compounds; Carcinoma Non-Small-Cell Lung; Cell Line Tumor; Cell Proliferation; Cell Survival; Female; Humans; Lung Neoplasms; Mice Inbred NOD; Mice SCID; Neoplastic Stem Cells; Nitrophenols; Piperazines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays; bcl-X Protein; Molecular Biology; Cell BiologyTumor BurdenAnimals; Antineoplastic Agents; Biphenyl Compounds; Carcinoma Non-Small-Cell Lung; Cell Line Tumor; Cell Proliferation; Cell Survival; Female; Humans; Lung Neoplasms; Mice Inbred NOD; Mice SCID; Neoplastic Stem Cells; Nitrophenols; Piperazines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays; bcl-X ProteinNeoplastic Stem CellsFemaleStem cellHumanmedicine.drugXenograft Model Antitumor AssayCell SurvivalPopulationbcl-X ProteinAntineoplastic AgentsBiologySCIDSulfonamideCell LineCancer stem cellCell Line TumormedicineAnimalsHumanseducationLung cancerPiperazineMolecular BiologyCell ProliferationSettore MED/04 - Patologia GeneraleOriginal PaperNitrophenolAnimalCell growthCarcinomaBiphenyl CompoundsCell Biologymedicine.diseaseXenograft Model Antitumor AssaysGemcitabineLung NeoplasmCell cultureBiphenyl CompoundCancer researchInbred NODNeoplastic Stem Cell
researchProduct

MILD COGNITIVE IMPAIRMENT (MCI): LA ZONA GRIGIA

2008

MCI ANZIANO DEFICIT COGNITIVO
researchProduct